DB30293ApprovedInvestigationalOrganism Based Therapies
Approved by the FDA under a Biologics License Application (BLA) as an acellular nerve scaffold for the treatment of adult and pediatric patients (aged ≥1 month) with sensory, mixed, and... Our team is working on the full update, which will be available soon.
- Also known as
- Acellular nerve allograft–arwx · Processed nerve allograft · Processed nerve allograft (human)
Resolves to
Clinical / RWD
What you can answer from here — as of June 24, 2026
Which companies are running trials of Acellular nerve allograft, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account